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Introduction
Globally, lung cancer is the most common cancer 
(2.09 million cases) and the leading cause of cancer 
mortality (1.76 million deaths) (1). In Australia lung cancer 
remains the leading cause of cancer mortality, accounting 
for nearly 1 in 5 (18%) cancer deaths, for both sexes (1 in 
20 for males and 1 in 30 for females) before the age of 85 (2). 
Lung cancer is associated with the highest proportion of 
cancer burden and a poor 5-year survival rate of 17% (range, 
68% stage I–3.2% for stage IV) (3), which is comparatively 
lower than other cancers (2). In 2016 to 2017, lung cancer 
was the second most common reason for a radiotherapy 
course (in both males and females) and the second most 
common type of cancer for palliative care hospitalization 
(13% of all cases) in Australia (2). Lung cancer is categorized 
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as non-small cell lung cancer in more than 80% of cases and 
small cell lung cancer in about 15% of cases (3).
Lung cancer is associated with significant morbidity, 
with the most distressing symptoms commonly reported by 
people including breathlessness, pain, fatigue, and anorexia 
(4,5). Symptoms experienced by people with lung cancer 
are often poorly managed, causing significant symptom 
burden. Effectively managing these physical and psycho-
social symptoms (6), which also affect caregivers (7), 
requires the input of a multidisciplinary team, including 
specialist palliative care. Specialist palliative care (at home 
or the hospital) has been shown to be associated with 
improved pain and symptom control, anxiety and reduced 
hospital admissions for people with advanced cancer (8), 
with benefits extending to caregivers while in the role 
and subsequently (9). There is limited evidence of its 
effectiveness on people’s quality of life, experience of care 
and economic cost (10).
The past few decades have seen a paradigm shift towards 
the provision of palliative care as integral to comprehensive 
care for people with advanced cancer. Earlier integration 
of palliative care within the oncology setting may be 
associated with improved patient outcomes (4,11,12). In a 
landmark study in 2010, Temel and colleagues (13) showed 
that early integration of palliative care reduced depression 
and symptom burden, and improved quality of life for 
people newly diagnosed with metastatic non-small cell lung 
cancer. Subsequently, two Lancet commissions have made 
recommendations for palliative care to be offered from the 
earliest stages in the disease trajectory, and concurrently 
with any curative and/or life-prolonging therapies (14,15). 
Earlier integration of palliative care into oncology care 
is also supported by national guidelines, including the 
American Society of Clinical Oncology (ASCO) Provisional 
Clinical Opinion (16) and the National Comprehensive 
Cancer Network (NCCN) Clinical Practice Guidelines in 
Oncology (17).
A recent systematic review reported mixed results for the 
effectiveness of early palliative care both in the outpatient 
and community setting, across various conditions (18). 
While some randomized controlled trials (RCTs) reported 
improvements (including improved depression, patient and 
caregiver quality of life, caregiver burden; increased use 
of advance care directives, patient and family satisfaction; 
reduced aggressive end-of-life care, hospitalizations, 
hospital length of stay, and medical care costs), other RCTs 
reported no evidence of improvement (in symptoms, quality 
of life and resource utilization and costs), when compared 
to “usual” care (18). Given the heterogeneity in patient 
populations, it is important to identify the sub-populations 
who would most benefit from early palliative care as part of 
their lung cancer care.
The aim of this review is to appraise the current evidence 
for the effectiveness of early integrated palliative care in 
improving outcomes for people with advanced (metastatic) 
lung cancer and their caregivers.
Methods
A systematic review conducted and reported according to 
the Preferred Reporting Items for Systematic Reviews and 
Meta-Analysis (PRISMA) guidelines (19). We reviewed 
studies reporting on the effectiveness of palliative care 
interventions provided to adult patients (≥18 years) with 
advanced (metastatic) small cell lung cancer (SCLC) or 
non-small cell lung cancer (NSCLC). Studies with mixed 
cancer cohorts were eligible for inclusion if they included 
participants with lung cancer clearly delineated in their 
sample size. Included studies were reports on phase II 
and phase III randomized controlled health service trials 
(RCTs) examining either (I) the efficacy of integrating early 
specialized palliative care alongside standard oncology 
care versus standard oncology care alone; or (II) providing 
individual palliative care interventions simultaneously with 
oncology care, for any outcome of interest. Secondary 
analyses and qualitative findings of RCTs were excluded, 
as were published protocols. Systematic reviews were also 
excluded, with primary studies screened for eligibility.
MEDLINE and PubMed were searched for primary 
studies published between 1 January 2010 and 31 July 2019, 
using Medical Subject Headings (MeSH) terms and text 
words for ‘lung cancer’ AND ‘palliative care’ OR ‘supportive 
care’ AND ‘randomized controlled trials’, limited to 
English. Database searches used the CareSearch palliative 
care filter (20,21). Database searching was supplemented 
with lateral searching of Google Scholar. Search results 
were imported into EndNote X9, and eligibility criteria 
applied to title/abstract screening and full text review 
(performed by S.K., in discussion with D.C.C.).
Data were extracted using an Excel proforma (Microsoft 
Office 2016) on: author, year, country, study design, sample 
(cancer stage; sample size), intervention/control, outcome 
measures, results, and author-identified conclusions. 
Intervention data were extracted using the Template 
for Intervention Description and Replication (TIDieR) 
checklist (22).
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Synthesis used meta-analysis where results for the same 
outcome measure were reported in comparable ways in two 
or more trials. Random effects models were used to allow 
for the possibility that between-group differences varied 
according to differences in sample characteristics (23). 
Summary measures were mean differences in scores on the 
outcome measures between groups. These were estimated 
as change from baseline wherever possible, or else at 
follow-up only where the former was not reported. Ninety-
five percent confidence intervals (CIs) were estimated. 
Heterogeneity was estimated using the Cochrane I2 statistic, 
and interpreted according to the Cochrane Handbook of 
Systematic Reviews as follows: 0% to 40% unimportant, 
30% to 60% moderate, 50% to 90%: substantial, and 75% 
to 100% considerable heterogeneity (24).
For outcomes where meta-analysis was not possible, 
synthesis used narrative methods (25) grouped around the 
type of intervention, and patient and caregiver outcomes, 
defined in the broadest sense.
Results
Of 485 records identified, 13 papers were included in 
the final analysis, reporting on 11 randomized controlled 
trials (RCTs) (Figure 1). Six RCTs, reported in the eight 
papers presented in Table S1, evaluated the effectiveness 
of delivering specialized palliative care alongside standard 
oncology care vs. standard oncology care alone (13,26-32) 
(Table S1). Two of these trials (27,30) reported their patient 
(27,30) and caregiver (28,31) outcomes separately, and are 
presented as such in Table S1. Five RCTs (33-37) evaluated 
the effectiveness of providing individual palliative care 
interventions simultaneously with oncology care (Table S2). 
All 11 trials were included in a narrative synthesis, but the 
heterogeneity of measures and the ways in which these were 
reported limited meta-analysis to two trials (26,27).
Study characteristics
All eleven trials were conducted in high income countries, 
with the majority conducted in the United States (n=5) 
(13,26-28,30,31,36), and the reminder conducted in 
Australia (37), Canada (32), Denmark (29), Singapore (34), 
Switzerland (33), and The Netherlands (35). Seven trials 
included people with various cancers (26-33,37), while 
four trials included lung cancer only (13,34-36). Four trials 
included people with cancer (‘patients’) and their family 
caregivers (‘caregivers’) (27,28,30,31,35,36) and seven trials 
Figure 1 PRISMA flow diagram of included and excluded studies.






















Full-text articles excluded (n=20):
•  Secondary analysis (n=10)
•  Not an RCT (n=5)  
•  Not lung cancer (n=3)
•  Not oncology (n=1)
•  Qualitative study (n=1) 
Records identified through database searching: 
MEDLINE (n=182) and PubMed (n=301)  
(n=483) 
Records after duplicates (n=155) removed
(n=331) 
Title/abstract screening (n=331) 
Full-text review (n=33) 
Studies included in narrative synthesis 
(n=13) 
Studies included in meta-analysis  
(n=2) 
Records identified through lateral searching  
(n=3) 
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included patients only (13,26,29,32-34,37).
Primary and secondary outcomes varied widely across 
studies, with the most common being quality of life and 
psychological symptoms (such as anxiety and depression). 
Others included symptom distress, functional status, 
and survivorship. For lung cancer specifically, the 
outcomes measured included: patient/caregiver quality 
of life and mood (including anxiety and depression); 
patient understanding of prognosis; patient-oncologist 
communication; aggressiveness of care at the end-of-
life, patient resuscitation preferences, and survivorship 
(13,27,28).
The components of early palliative care interventions in 
the eight RCTs that evaluated the effectiveness of delivering 
specialized palliative care alongside standard oncology care 
compared to usual oncology care alone (13,26-32) were 
quite similar (Table S3). Overall, early referral interventions 
involved consultations with a specialist palliative care team 
(with various members) or palliative care physician or an 
advance practice nurse. Delivery was in person (in clinics or 
at home) or over the phone. Interventions were delivered: 
within 4 weeks of enrolment and at least monthly until 
death (27,28); within 3 weeks after recruitment and at least 
monthly until death (13); tailored to patient need (29); 
within 30–60 days after diagnosis (early intervention) or 
3 months after diagnosis (delayed intervention) (30,31); 
within 24 hours of diagnosis followed by phone and in-
person contacts (26); within 1 month of recruitment 
followed by a routine phone call one week after the initial 
consultations and thereafter as needed, as well as a monthly 
outpatient palliative care follow up (32).
Synthesis of results
Effectiveness of providing specialized palliative care 




Survival data for early palliative care were drawn from 
two studies, one specifically evaluating outcomes in lung 
cancer (13), the other evaluating outcomes in a number of 
cancer populations including lung cancer (30). Compared to 
usual oncology care, early palliative care was associated with 
less premature mortality in people newly diagnosed with 
lung cancer (13). Longer one year survival was reported for 
people with advanced cancer (including lung cancer) for 
whom palliative care was initiated within 30 to 60 days of 
diagnosis, compared to those who received palliative care 
3 months after their diagnosis (63% vs. 48%; difference, 
15%; P=0.038) (30).
(II) Quality of life
Quality of life was an outcome of interest in three studies, 
including two which evaluated this in patients with metastatic/
incurable lung cancer (13,27) and one which evaluated 
this in patients with advanced cancer prognosis including 
lung cancer (32). Early palliative care was associated with 
improved quality of life at 24 weeks, but not at 12 weeks (27). 
For people with lung cancer specifically, quality of life 
improved at week 12 and 24 for the intervention group but 
deteriorated for the control group (27). Compared to usual 
oncology care, early palliative care was found to improve 
quality of life for people newly diagnosed with lung 
cancer (13). Similar findings have been replicated in another 
trial which found that early palliative care improved quality 
of life and satisfaction with care for people with advanced 
lung cancer (32).
(III) Treatment and health care utilization
Four studies evaluated the effect of early palliative care 
on treatment preferences and health care utilization, in 
lung cancer (13) and mixed-cancer populations (27,30,32). 
Early referral to palliative care appeared to impact on the 
patient-treating clinician relationship, with people in the 
intervention group (compared to usual care) more likely 
to discuss their wishes with their oncologists if they were 
dying (27) and having less aggressive treatment at the end of 
life (13). However, another trial found that early palliative 
care did not change the issues discussed during medical 
interactions (32). For people with advanced cancer receiving 
palliative care early (within 30–60 days after diagnosis) 
or later (3 months after diagnosis), similar relative rates 
between the two groups were reported for hospital and 
intensive care unit days, emergency department visits, 
chemotherapy in the last 14 days, and home deaths (30).
(IV) Depression
Two studies with focus on lung cancer evaluated the impact 
of early palliative care on depression (13,27). Early palliative 
care was found to lower depression at 12 weeks (27). For 
people with lung cancer in particular, depression improved 
at week 12 and 24 when receiving early palliative care 
but deteriorated for those receiving usual oncology care 
only (27). Another trial reported fewer depressive symptoms 
for people in the intervention group receiving early 
palliative care (13). 
A meta-analysis could be conducted for the Patient 
Health Questionnaire 9 (PHQ-9) (38) used in two studies 
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(26,27). PHQ-9 measures depression on a nine-item 
scale, with higher scores indicating greater depression. 
Scores could be converted into five ordinal descriptors of 
depression. Results from these two studies found a non-
significant difference between early palliative care versus 
standard oncology (P=0.53); however, heterogeneity was 
substantial (Figure 2).
(V) Other symptoms
Symptom outcomes were measured in four studies 
evaluating the effectiveness of early palliative care compared 
to standard oncology care (29,32) or enhanced usual 
oncology care (26) or delayed palliative care (30). Patient-
reported outcomes (symptom impact, mood) were not 
statistically significant for people with advanced cancer 
(including lung cancer) receiving early palliative care 
(within 30 to 60 days of diagnosis) vs. delayed palliative care 
(3 months after diagnosis) (30). For people with advanced 
lung cancers,  early intervention did not improve 
symptom and emotional distress, and personal and social 
dependency (26) or reduce symptom severity (32). Early 
specialist palliative care did not improve patients’ primary 
needs (where the primary need was the patient-identified 
symptom or problem with highest intensity, including 
physical function, role function, emotional function, pain, 
nausea/vomiting, breathlessness, and lack of appetite) (29). 
In another trial, physical and emotional symptoms either 
remained stable or improved slightly for both the early 
intervention and usual care group (26).
(VI) Self-efficacy
Self-efficacy was a secondary outcome in one study 
evaluating the effects of multidisciplinary palliative care 
compared to enhanced usual care (26). For people with 
incurable (lung) cancer, personal competence (comprised of 
six daily living activities: eating, dressing, walking, traveling, 
bathing, and toileting) improved in both early palliative care 
intervention and usual care groups, while social competence 
(comprised of activities in the home, work activities, social 
and recreational roles, and communication) improved in the 
usual care group only (26). Perceptions of own health over 
time worsened for both groups (26). Enhanced usual care 
significantly improved self-efficacy and reduced uncertainty 
at 1 and 3 months (compared to the intervention) (26).
(VII) Communication
For people with advanced cancers (various), early 
involvement of specialist palliative care was not effective 
in improving medical interactions (32). However, people 
receiving early palliative care (compared to usual oncology 
care) were more likely to discuss their wishes with their 
oncologists if they were dying (27).
Caregivers
Early palliative care for people with lung cancer was effective 
in improving caregivers’ total distress and depression, 
but not anxiety or overall quality of life at 12 weeks (28). 
No differences in caregivers’ psychological and quality of 
life outcomes were observed at 24 weeks (28). Caregivers 
reported significantly lower depression and anxiety at 3 
and 6 months before the death of the person with cancer; 
again, no such difference was reported for overall quality 
of life (28). For caregivers of people with advanced cancer 
(including lung cancer), early vs. delayed palliative care 
improved depression and stress burden in the terminal 
analysis; there were no differences in quality of life or 
burden for either group (31).
Effectiveness of providing individual palliative care 
interventions simultaneously with oncology care
Patients
(I) Quality of life
In people with metastatic or locally advanced lung or 
gastrointestinal cancers, an interventional program of 
nutrition and physical exercise did not improve overall health-
related quality of life compared to usual care (33). In mixed 
patient populations (including people with lung cancer), a 
nurse-directed face-to-face educational intervention resulted 
in no significant difference between intervention and control 
groups in quality of life at 12 weeks after baseline (34). 
Figure 2 Results from meta-analysis of Patient Health Questionnaire 9 (PHQ-9) used in two studies comparing early palliative care 
alongside oncology care versus standard oncology alone.
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In people with inoperable lung cancer (predominantly 
non-small cell lung cancer), consultations and systematic 
needs assessment as part of patient’s multidisciplinary team 
meetings (vs. usual care where no such systematic assessment 
was provided at multidisciplinary team meetings) did not 
improve quality of life (37).
(II) Other symptoms
Nutrition and physical exercise (compared to usual care) 
reduced nausea and vomiting (P=0.023) and increased 
protein intake (P=0.01) (33). Compared to usual care, 
no statistical differences were found for energy intake, 
nutritional status and physical performance (33). A nurse-
directed face-to-face educational intervention resulted in 
no significant difference between intervention and control 
groups in mood at 12 weeks after baseline (34). Providing 
systematic needs assessment during consultations and 
multidisciplinary team meetings (vs. usual care where 
no such systematic assessment was provided) found no 
improvement in unmet needs assessment, psychological 
morbidity or distress (37). Change score analysis indicated 
a relative benefit from the intervention for unmet symptom 
needs at week 8 and 12 post-assessment (effect size =0.55 
and 0.40, respectively) (37).
(II) Communication
All patients undertaking a nurse-directed face-to-face 
educational intervention reported satisfaction with the 
topics of discussion (including symptom management, 
problem solving, communication, and advance care 
planning), finding them useful (34).
Caregivers
Providing mindfulness-based stress reduction training 
to people with lung cancer, found no effect on their 
caregivers’ psychosocial distress (including quality of life, 
mindfulness skills, self-compassion and rumination) (35). 
Offering telephone symptom management (TSM) (with 
cognitive-behavioral and emotion-focused therapy content) 
vs. education/support found no significant group differences 
in improving the caregiver self-efficacy for helping the 
person with lung cancer manage cancer symptoms as well 
as caregiver burden at 2 and 6 weeks post-intervention (36). 
A small improvement favoring TSM was observed in 
caregivers’ self-efficacy to manage their own emotions and 
perceived social constraints from the patient, but no significant 
changes were reported over time for either group (36).
Discussion
There is mixed evidence for the effectiveness of early 
referral to palliative care and individual palliative care 
interventions for people with lung cancer and their 
caregivers. The two major positive trials testing the 
effectiveness of early referral to palliative care focused 
on lung cancer (13,27). It is noteworthy that these trials 
were conducted at a single US site and in a country 
where concurrent palliative care and active oncology 
treatment has only recently been funded (39). All other 
trials were conducted with heterogeneous advanced cancer 
populations, at single or multiple centers, and some were 
conducted in countries where universal health care may also 
be available. The trials evaluating individual interventions 
were predominantly conducted at single sites, in countries 
with and without universal health care coverage. Four of the 
five trials focused exclusively on lung cancer. Their results 
were equally inconclusive in relation to the effectiveness of 
the proposed palliative care interventions.
This lack of conclusive evidence for lung cancer 
parallels findings for the effectiveness of early referral to 
palliative care in other cancer populations. Trials reporting 
advantages of providing early referral to palliative care 
include people newly diagnosed with gastrointestinal (GI; 
non-colorectal) cancer, where early referral decreased 
depression, improved patients’ quality of life and ability to 
cope with the prognosis, and enhanced patient-clinician 
communication about end-of-life preferences (27). 
Importantly, the trial reported that quality of life and mood 
at week 12 improved for both the intervention and control 
groups (27). Breathlessness support services were found to 
improve mastery of breathlessness in people with advanced 
diseases, including lung cancer (40). Early integration of 
palliative care also improved survival (at 6 months and 
overall), but only for people with chronic obstructive and 
pulmonary disease (COPD) and interstitial lung disease, 
and not those with lung cancer (40).
Mixed results or lack of improvement within trials have 
also been noted. In people with gastric cancer, systematic 
early palliative care (compared to on-demand palliative 
care) showed slight, but not significant benefit in improving 
quality of life; and no improvement in anxiety/depression 
and family satisfaction with care (41). Similarly, people 
with advanced pancreatic cancer receiving systematic (vs. 
on-demand) palliative care reported improved quality of 
life and symptom burden, and reduced hospitalization; 
but not overall survival (42). Early specialist palliative 
care compared to standard oncology care in people with 
malignant pleural mesothelioma (a cancer with high 
symptom burden and poor survival) did not improve quality 
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of life nor psychological symptoms (depression and anxiety), 
suggesting that routine referral to specialist palliative care 
soon after diagnosis is not needed if access to such services 
can be provided when needed (43).
The same mixed benefits of integrating early palliative 
care in standard oncology care extends to caregivers. In 
gastrointestinal (non-colorectal) cancer, early palliative care 
was associated with improved caregiver total distress and 
depression, but not anxiety at 12 weeks (28). Although the 
same benefits were not observed at 24 weeks, significant 
benefits were observed for both depression and anxiety at 3 
and 6 months before the patient’s death (28).
Despite these limitations, earlier integration of palliative 
care into oncology care is supported by national guidelines, 
including for people newly diagnosis with people with non-
small cell lung cancer (17). The recommendations further 
state that screening for palliative care needs should be 
continuous, at appropriate intervals as clinically indicated (17).
Defining the intervention elements and measuring fidelity
Despite great excitement after the Temel et al. (13) trial, 
the demonstrated survival advantages have not been 
reproduced other than in another US trial conducted by 
Bakitas et al. (30). In determining the effects of palliative 
care on survivorship, it is worth asking if these trials 
observed increased survival in the intervention group or 
increased mortality in the group that did not get palliative 
care. It is possible that what has been observed in these 
trials is not improved survival but premature mortality 
in the control group who did not get access to palliative 
care (44). Given the (perceived or actual) benefits of 
palliative care for both patients and caregivers (during 
and after the caregiving period) (9,31), lack of access to 
palliative care is likely to increase the burden of the disease 
on people’s lives, including their survivorship. Delineating 
these effects in future trials is important, yet challenging, 
and will have implications for the design of future studies, as 
well as our understanding of the true net effect of palliative 
care for the cancer population in general, and lung cancer 
in particular.
Another important consideration when determining 
the correlation between the effects observed in these 
trials and the active intervention is understanding what 
element(s) within palliative care make the most difference 
for participant’s outcomes. The five trials included in this 
review testing individual palliative care interventions in the 
oncology setting (Table S3) integrated different therapeutic 
elements into their palliative care interventions. The use of 
mindfulness-based techniques was reported as a potentially 
helpful therapy to reduce patients’ distress, which is 
supported by previous research in other populations with 
cancer (45). However, more robust data is required to 
draw definite conclusions. Evidence is still conflicting 
for other interventions such as nutrition and exercise-
based programs (46). This is important given the adverse 
impact of cachexia and muscle wasting on quality of life, 
survivorship and caregiver distress. Most trials evaluate 
different interventions as part of a comprehensive palliative 
care model of care. Thus, it might be difficult to determine 
the relevance and impact of each component on the patient/
caregiver outcomes. Other factors [for example, who 
delivers palliative care, the oncologist or the palliative care 
specialist (4)] might also play a role.
Definitional issues are also relevant when trying to 
unpack the components of “early” palliative care. Lack of 
consensus around “early” palliative care (18) means that 
this is defined in relation to multiple entry points, and can 
include any of the following: initial consultation at time 
of diagnosis; being seen by a palliative care specialist less 
than 3 months after diagnosis of advanced cancer or greater 
than 3 months before death; at particular treatment time 
points specific to cancer type (for example, at the time of 
cisplatinum resistance for advanced ovarian cancer) (18). 
Early palliative care can also be tied to the presence of 
prognostic signs or symptoms; or defined in relation to 
the setting (e.g., outpatient vs. inpatient) or duration of 
continuity before death (>90, 31–90, 11–30, 1–10 days) (18). 
This variation will particularly be relevant in multi-site 
trials where local practices and models of care are likely to 
influence the components and delivery of the intervention 
and controlled arms (44).
Equally importantly, lack of consensus around what is 
best supportive care or usual/standard care means that often 
these are not clearly defined in trials (47). An international 
Delphi-consensus process identified four key domains of 
best supportive care in clinical trials: multi-disciplinary care; 
supportive care documentation; symptom assessment; and 
symptom management (48). Incorporating this in the design 
of the control (but also active) arm will have implications in 
how these trails are conducted and outcomes compared (44).
Implications for the provision of multidisciplinary care in 
lung cancer
If multidisciplinary care is the gold standard of optimal care 
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for people with lung cancer, how does integrating early 
palliative care affect this model of care, if at all? Evidence 
suggest that multidisciplinary teams in lung cancer are 
effective in changing patient management, more so than 
in improving survival (for which there is limited evidence) 
(49,50). If multidisciplinary care is the standard and if 
palliative care is part of multidisciplinary lung cancer care, 
are the benefits associated with its initiation associated with 
early referral as routine practice or based on individual 
patient and caregiver needs?
Although studies have shown that a delayed initiation of 
palliative care results in poorer outcomes for people with 
cancer (when compared to early initiation after diagnosis) (30), 
studies comparing systematic vs. needs-based palliative care 
show no significant differences in survival (42), quality of 
life, psychological symptoms and family satisfaction with 
care (41). This suggest that providing palliative care when 
required might achieve the same outcomes for patients and 
caregivers. On-demand palliative care may also be a more 
cost-effective option.
A key element of providing multidisciplinary palliative 
care is the inclusion of primary care providers as part 
of the multidisciplinary care teams. Of the included 
trials in this review, only one trial (29) involved general 
practitioners in the provision of palliative care and only as 
part of standard oncology care (i.e., the control arm, where 
specialist palliative care was the intervention arm). Perhaps 
significantly, providing early specialist palliative care in this 
trial showed no significant effect on the primary outcome 
(which was the patient’s identified need), and no differences 
between the groups in relation to other patient-identified 
symptoms, including survivorship. None of the included 
trials in this review included primary care providers in their 
palliative care intervention. Facilitating the engagement of 
general practitioners in multidisciplinary care teams may 
provide benefit to patients and their caregivers as their 
palliative care needs would be supported in the environment 
in which they live (i.e., at home as opposed to the hospital). 
Supporting their involvement through evidence-based 
methods, such as case conferencing (51), could have the 
potential to add to the quality of clinical decision making 
within multidisciplinary teams (52), ultimately resulting in 
improved patient and caregiver outcomes.
Strengths and limitations
There are a number of strengths and limitations with this 
systematic review. Its strengths are having examined all of 
the data from the early palliative care trails and synthesized 
the results, a number of recommendations are made about 
current practice and future research. Its major limitation is 
that only two of the included trials had ≥50% of participants 
with lung cancer, while the others included participants with 
various cancers. The latter studies did not report the lung 
cancer data separately. Therefore, the results reported here 
reflect outcomes reported for all cancers making it difficult 
to know to what extend those findings can be generalized 
for lung cancer specifically. However, cancers with poor 
outcomes such as gastrointestinal were included, which 
makes for comparable outcomes. Variability in outcome 
measures and reporting reduced our capacity to synthesize 
results quantitatively.
Conclusions
Mixed results were found in the literature for the effectiveness 
of early referral and for specific components of supportive 
care for people with lung cancer and their caregivers, 
mirroring findings for other types of cancer. Combined with 
evidence that on-demand palliative care is equally, if not 
more effective than systematic palliative care, this raises the 
question of whether initiation and provision of palliative care 
as part of multidisciplinary lung cancer care should be guided 
by an early or need-based referral. Better understanding of 
the “active ingredients” of palliative care when delivered 
to people with lung cancer and their caregivers will help 
delineate the correlation with reported outcomes.
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Table S1 Randomized controlled trials evaluating specialized palliative care interventions + standard oncology care vs. stand oncology care alone
Author, year, country Aim Sample Intervention Control Outcome measures Results Conclusions
El-Jawahri et al., 
2017 (28), USA, non-
blinded randomized 
trial, single site
To evaluate the effects of 
early integrated palliative 
care on caregiver-
reported outcomes in 
patients with newly  
diagnosed incurable 
cancers
Caregivers of people with incurable lung 
(NSCLC, SCLC, mesothelioma) or non-
colorectal gastrointestinal (GI) cancers: 
total (n=275); intervention (n=137); control 
(n=138)
Early integrated palliative 
care & oncology care; 
meeting with a PC clinician 





• Patient mood and anxiety—Hospital Anxiety 
and Depression Scale (HADS) 
• Patient QOL—Medical Health Outcomes 
Survey-Short Form (SF-36) 
Secondary 
• Caregiver mood and anxiety—HADS 
• Caregiver QOL—SF-36
• Improvement in caregivers’ total distress, depression subscale, but not anxiety 
subscale or QOL at week 12 
• No differences in caregivers’ outcomes at week 24 
• Significant effects on caregivers’ total distress (both anxiety and depression) 
at 3 and 6 months before patient death, but no difference in caregiver reported 
QOL
Early involvement of palliative 
care for patients with 
newly diagnosed lung and 
gastrointestinal cancers leads 
to improvement in caregivers’ 
psychological symptoms; the 
benefits of early, integrated 
palliative care models in 
oncology care extend beyond 
patient outcomes and positively 
impact the experience of 
caregivers
Groenvold et al., 




To investigate the 
potential impact of early 
specialist palliative 
care in patients with 
advanced cancer and 
palliative care needs
297 patients with stage IV cancer of any 
type, or stage III/IV cancers in the central 
nervous system (145 to intervention, 
152 to control): cancer in the lung 
(39% in intervention, 30% in control), 
digestive system (14% in intervention, 
25% in control), or the breast (21% 
in intervention, 23% in control), other 
cancers in stage IV or cancers in the CNS 
of grades III/IV (26% in intervention, 22% 
in control)
Early specialist palliative 
care was defined as ‘usual 
specialist palliative care’ 
initiated earlier than what 
otherwise would have 
been the case. Patients in 
intervention group were 
referred to a specialist 
palliative care team. 
Treatments and other 
interventions were determined 
by the patient’s needs
Standard care only. 
Standard care 
included palliative 
care provided by 
the departments of 
oncology, general 
practitioners (GPs) 
or home care 
services
Primary
• Change in patient’s primary need—7 of 15 
scales from EORTC-QLQ: physical function, role 
function, emotional function, nausea/vomiting, 
pain, dyspnea and lack of appetite Secondary 
• Changes in the seven QLQ-C30 scales
• Early specialist palliative care had no significant effect on the primary 
outcome over 8 weeks (P=0.14) 
• Separate analyses of each of the seven scales showed no differences 
between intervention and control groups; the exception was nausea/
vomiting, showing the largest change (P=0.013, 0.01 threshold) favoring the 
intervention 
• Survivorship did not differ between the two groups (P=0.16, P=0.39 in fully 
adjusted analysis)
This RCT did not show 
beneficial or harmful effects of 
early specialist palliative care in 
advanced cancer patients with 
palliative care needs.




To evaluate the effects of 
early integrated palliative 
care on patient-reported 
outcomes in patients 
with newly diagnosed 
incurable cancers
• People within 8 weeks of a diagnosis 
of incurable lung (NSCLC, SCLC, 
mesothelioma) or non-colorectal GI 
(pancreatic, esophageal, gastric or 
hepatobiliary) cancer: total (n=350); 
Intervention (n=175); Control (n=175).  
• Lung cancer: intervention (n=96, 54.9%) 
control (n=95, 54.3%).  
• Non-colorectal GI cancer: intervention 
(n=79, 45.1%); control (n=80, 45.7%)
Early integrated palliative 
care & oncology care 
Meeting with a palliative care 





• QOL—Functional Assessment of Cancer 
Therapy-General (FACT-G) scale 
Secondary 
• Mood and anxiety—Patient Health 
Questionnaire-9 (PHQ-9); HADS 
• Patients’ understanding of prognosis and 
report of communication with oncologists—
Prognosis and Treatment Perceptions 
Questionnaire
• Greater improvement in the intervention group in QOL baseline to week 24 
(1.59 vs. −3.40; P=0.010) but not week 12 (0.39 vs. −1.13; P=0.339) 
• Lower depression in the intervention group at week 24, controlling for baseline 
scores (adjusted mean difference, −1.17; 95% CI, −2.33 to −0.01; P=0.048) 
• Improved QOL and depression at week 12 and 24 (patients with lung cancer; 
intervention) vs. deterioration in both (patients with lung cancer; usual care) 
• Improved QOL and mood by week 12 (patients with GI cancers; both groups) 
• Intervention vs. usual care patients: more likely to discuss their wishes with 
their oncologist if they were dying (30.2% vs. 14.5%; P=0.004)
For patients with newly 
diagnosed incurable cancers, 
early integrated palliative care 
improved QOL and other salient 
outcomes, with differential 
effects by cancer type; early 
integrated palliative care may be 
most effective if targeted to the 
specific needs of each patient 
population





To compare the effect 




survival, and resource 
use
• Total (n=207): early intervention (n=104), 
delayed intervention (n=103) 
• Lung cancer: early group (n=46, 44.2%), 
delayed group (n=42, 40.8%) 
• GI tract: early group (n=26, 25%), 
delayed group (n=24, 23.3.8%) 
• Breast: early group (n=10, 9.6%), 
delayed group (n=13, 12.6%) 
• Genitourinary tract: early group (n=10, 
9.6%), delayed group (n=13, 12.6%) 
• Hematologic malignancy: Early group 
(n=5, 4.8%), delayed group (n=5, 4.8%)
Outpatient palliative care 
consultation and six 
structured weekly telephone 
coaching with an advanced 
practice nurse
Patients in the 
delayed group 
received initiation 
of PC months 




 Quality of Life—46-item Functional 
Assessment of Chronic Illness-Therapy—
Palliative Care (FACIT-Pal)  
 Symptom impact—Quality of Life at End of 
Life (QUAL-E) 
 Mood—Centre for Epidemiologic Studies—
Depression Scale (CES-D) 
• One-year and overall survival 
• Resource use and location of death
• There were no significant differences between the early palliative care and 
delayed groups in QOL, symptom impact and moon 3 months after enrolment 
• There were no significant differences in analyses of decedents’ outcomes looking 
backward from death at 12, 6, or 3 months 
• There was a 15% difference in survival at 1 year (early group, 63% vs. delayed 
group, 48%; P=0.038) 
• Median survival was 18.3 months for the early group (n=50) and 11.8 months 
for the delayed group (n=59), but the log-rank test was not significant (P=0.18) 
• There were trends towards rates of hospital, ICU days and ED visits in the early 
group compared to the delayed group, but this was not significant 
• Use of chemotherapy in the last 2 weeks of life was not statistically different 
(1.57; 95% CI, 0.37 to 6.7; P=0.54) 
• There were no significant differences in the number of decedents who died at 
home in the early (n=27, 54%) or delayed intervention (n=28, 47%)
This study supports the 
association between early 
palliative care and improved 
survival, but the mechanisms 
by which this occurs requires 
further research
Dionne-Odom et al. 




To determine the effect 
of early vs. delayed 
initiation of a palliative 
care intervention for 
family caregivers of 
people with advanced 
cancer
• 122 caregivers (early group, n=61; 
delayed group, n=61). 
• Lung (early group, n=28, 45.9%; 
delayed group, n=25, 41%);  
• Gastrointestinal (early group, n=14, 
23.0%; delayed group, n=17, 27.9%); 
genitourinary (Early group, n=5, 8.2%; 
delayed group, n=5, 8.2%) 
• Breast (early group, n=5, 8.2%; delayed 
group, n=5, 8.2%) 
• Hematologic (early group, n=3, 4.9%; 
delayed group, n=4, 6.6%) 
• Other solid tumor (early group, n=6, 
9.8%; delayed group, n=5, 8.2%)
Outpatient palliative care 
consultation and telephone 




care 3 months 
after diagnosis
• Caregiver QOL (CQOL-C) 
• Caregiver Depressed mood – Center for 
Epidemiologic Study–Depression Scale (CESD) 
• Caregiver Objective, stress, and demand 
burdens—Montgomery-Borgatta CG Burden 
(MBCB) subscales
• The intervention led to lower depression in the early group compared to the 
delayed group (mean difference, −3.4; SE, 1.5; d=−0.32; P=0.02) 
• There were no significant differences in QOL (mean difference =−2; SE 
=2.3; d=−0.13; P=−0.39) or burden (objective burden: mean difference =0.3; 
SE=0.7; d=0.09; P=0.64; stress burden: mean difference =−0.5; SE= 0.5; 
d=−0.2; P=0.29; demand burden: mean difference=0; SE=0.7; d= -0.01; 
P=0.97) compared with initiation 3 months later
The telephone based and 
prompt provision of this 
intervention may have been key 
elements to the convenience 
of this intervention, and its 
ability to teach and foster 
skills in caregivers that could 
be successfully applied and 
integrated over time. Future 
work should further devise ways 
to alleviate the caregiver burden 
and optimize their physical 
health
McCorkle et al. 
2015 (26), USA, 
cluster-randomized 
controlled trial, four 
disease-specific 
clinics at a single site
To evaluate the effects 
of a multidisciplinary 
intervention coordinated 
by advance practice 
nurses (APNs) on 
patient-reported 
outcomes in patients 
newly diagnosed with 
late-stage cancers
• Late-stage cancer diagnosis; post-
biopsy or surgery with additional 
treatment recommended; at least one 
self-reported chronic condition 
• Total (n=146): intervention (n=66), 
control (n=80) 
• Randomized to the intervention: 
gynecologic (n=20) and lung (n=16) clinics 
• Randomized to the control: head and 
neck (n=17) and gastrointestinal (n=39) 
clinics
Multidisciplinary intervention 
coordinated by an advanced 
practice nurse (APN)
Enhanced usual 
care group (usual 
multidisciplinary 
care plus a  




instructions on its 
use)
Primary and secondary 
• Symptom distress—Symptom Distress Scale 
(SDS) 
• Health distress—four-item scale developed by 
the Stanford Patient Education Research Center 
• Functional status—Enforced Social 
Dependency Scale (ESDS) 
• Self-rated health (physical and mental)—1st 
item of SF-12 
• QOL—FACT-G) (version 4) 
• Anxiety—HADS 
• Depression—PHQ-9 
• Uncertainty—Mishel Uncertainty in Illness 
Scale-Community Form (MUIS-C) 
• Self-efficacy—Self-Efficacy for Managing 
Chronic Disease Scale (SEMCD 6)
• No differences between the two groups on the primary patient-reported 
outcomes at 1 and 3 months post-baseline: symptom distress, emotional 
distress, enforced social dependency (persona and social) 
• Both groups: significant improvement on personal competence 
• Only enhanced usual care: significant improvement on social competence 
• Both groups: worse perceptions of their own health over time 
• Physical and emotional symptoms remained stable or significantly improved 
from baseline for both groups 
• Overall, secondary outcomes remained stable within the groups; but 
patients who received the enhanced usual care reported significantly 
better self-efficacy at 1 month (P<0.0097) and less uncertainty at 1 month 
(P<0.0007) and 3 months (P<0.0.106) compared to the intervention group
If patients newly diagnosed 
with late-stage cancer were 
managed by disease-specific 
multidisciplinary teams who 
palliated their symptoms, 
providing whole patient care, 
patient outcomes remained 
stable or improved
Zimmermann et al. 




To assess the effect of 
early palliative care in 
patients with advanced 
cancer on several 
aspects of quality of life
• Advanced cancer prognosis 6–24 
months: lung cancer (n=101; 43.81%), 
gastrointestinal (n=139; 60.4%), 
genitourinary (n=78; 33.7%), breast (n=72; 
31.3%), gynecological (n=71; 30.8%)
• Total (n=461) [Intervention (n=228), 
Control (n=233)] 
• Lung cancer: total (n=101); intervention 
(n=55; 24.1%), control (n=46; 19.7%)
Consultation and follow-
up in the oncology palliative 
care clinic by a palliative care 




Primary and secondary 
• QOL—Functional Assessment of Chronic Illness 
Therapy Spiritual Well-Being (FACIT-Sp); QUAL-E 
• Symptom severity—Edmonton Symptom 
Assessment System (ESAS) 
• Satisfaction with care—FAMCARE-P16  
• Problems with medical interactions—Cancer 
Rehabilitation Evaluation System Medical 
Interaction Scale (CARES-MIS)
At 3 months: 
• No difference for FACIT-Sp; 
• Significant difference in QUAL-E and FAMCARE-P16 favoring the 
intervention group; 
• No difference in ESAS and CARES-MIS.  
At 4 months: 
• Improvement for all measures except CARE-MIS, favoring the intervention 
group
Although the difference in 
quality of life was non-significant 
at the primary endpoint, this trial 
shows promising findings that 
support early palliative care for 
patients with advanced cancer





To examine the effect 
of early palliative 
care integrated with 
standard oncologic care 
on patient-reported 
outcomes, the use of 
health services, and the 
quality of end-of-life care 
among patients with 
metastatic non-small cell 
lung cancer
• People with metastatic, non-small cell 
lung cancer 
• Total (n=151): Intervention (n=76), 
Control (n=75)
Consultation and follow-up 
with palliative care physician/
advance practice nurse; 
Guidelines for palliative care 
in the ambulatory setting 
(National Consensus Project 





• QOL—Trial Outcome Index (TOI); Functional 
Assessment of Cancer Therapy-Lung (FACT-L); 
Lung cancer subscale (LCS); 
Secondary 
• Anxiety and depression—HADS; PHQ-9 
• Aggressive care at the end of life—
chemotherapy within 14 days before death; no 
hospice care; or admission to hospice 3 days or 
less before death 
• Patients’ resuscitation preferences—
documented in medical records
The intervention group showed 
• Improved QOL TOI 6.0 (FACT-L mean score 98.0 vs. 91.5; P=0.03 and LCS 1.7) 
• Fewer depressive symptoms (16% vs. 38%; P=0.01) 
• Fewer people received aggressive end-of-life care (33% vs. 54%; P=0.05) 
• Longer median survival (11.6 vs. 9.8 months; P=0.02)
Among patients with metastatic 
non-small cell lung cancer, early 
palliative care led to significant 
improvements in both quality of 
life and mood; compared with 
patients receiving standard care, 
patients receiving early palliative 
care had less aggressive care at 
the end of life but longer survival
Supplementary
Table S2 Randomized controlled trials evaluating individual palliative care interventions vs. standard/usual oncology care
Author, year, country Aim Sample Intervention Control Outcome measures Results Conclusions
Uster et al. 2018 (33); 
Switzerland; Two-
arm, parallel group, 
randomized controlled 
trial; single site
To test the effects of a 
combined nutrition and 
physical exercise program 
on cancer patients with 
metastatic or locally 
advanced tumors of the 
gastrointestinal and lung 
tracts
• Metastatic or locally advanced tumors of the 
gastrointestinal (n=38) and lung (n=20) tracts 
• Total (n=58); Intervention (n=29); Control (n=29) 
• NSCLC: total (n=16); intervention (n=9; 31.0%); 
control (n=7; 24.1%) 
• SCLC: total (n=4); intervention (n=2; 6.9%); control 
(n=2; 6.9%)
3 month nutrition and 
physical exercise program
Usual care (standard 
oncology care; maintain 
usual daily physical activity 
level; nutritional support 
provided only when medically 
indicated)
Primary 
• QOL—European Organization for Research and 
Treatment of Cancer Quality of Life Questionnaire V3.0 
(EORTC QLQ-C30) 
Secondary 
• Dietary intake—3 day food diaries) 
• Nutritional status—body weight (bioelectrical impedance 
analysis) 
• Physical performance—handgrip strength, 6-min walk 
and timed sit-to-stand test 
• Clinical data—unplanned admission, total length of all 
hospital stays, performance status (ECOG)
• No difference in global health status/
quality of life (overall QoL) post 
intervention (improvement in both 
groups) 
• Reduced nausea and vomiting 
(P=0.023) and increased protein intake 
(P=0.01) in the intervention group 
• No statistical differences for energy 
intake, nutritional status and physical 
performance
Good adherence to a 
combined nutrition and 
exercise program; the 
multimodal intervention did 
not improve overall QOL, but 
contributed to an adequate 
protein intake and to the 
general well-being of the 
patient by reducing nausea 
and vomiting
Yang et al. 2018 (34); 
Singapore; pilot, 
randomized phase II trial; 
single site
To determine feasibility 
and acceptability of the 
Enhancing Quality of Life in 
Patients (EQUIP) intervention; 
data completion rate of 
patient reported outcome 
measures in the trial; the 
estimated effect of the EQUIP 
intervention on quality of life 
and mood
• New diagnosis of stage 3 (n=21) or 4 lung cancer 
(n=48) 
• Total (n=69): Intervention (n=35); Control (n=34) 
• Adenocarcinoma: intervention (n=19; 54.3%); 
control (n=22; 64.7%)  
• SCLC: intervention (n=7; 20%); control (n=6; 
17.7%) 
• Squamous cell carcinoma: intervention (n=4; 
11.4%); control (n=4; 11.8%) 
• Others: intervention (n=5; 14.3%); control (n=2; 
5.9%)
Usual care plus patients 
individually received the 
EQUIP intervention (4 
face-to-face educational 
sessions with a nurse)
Usual care (standard 
oncology care as well 
as referral for palliative 
care services if deemed 
appropriate by the primary 
oncologist)
Primary 
• QOL—Chinese validated Functional Assessment of 
Cancer Therapy-Lung (FACT-L); Lung Cancer Subscale 
(LCS); Trial Outcome Index (TOI) 
Secondary 
• Mood—Chinese validated Hospital Anxiety and 
Depression Scale (HADS)
• No significant difference between 
intervention and control groups in 
quality of life and mood at 12 weeks 
after baseline 
• All patients were satisfied with the 
topics shared and felt they were useful
Nurse-directed face-to-face 
educational sessions were 
feasible and acceptable 
to patients with advanced 
lung cancer; however, there 
was no indication of benefit 
of the EQUIP intervention 
on quality of life and mood 
(which could be due in part to 
a low prevalence of targeted 
symptoms)
Schellekens et al. 2017 
(35); The Netherlands; 
parallel group randomized 
controlled trial; multi-site
To examine the effectiveness 
of mindfulness-based stress 
reduction (MBSR) added 
to care as usual (CAU) vs. 
CAU alone in reducing 
psychological distress in lung 
cancer patients and/or their 
partners
• Patients and/or partners of patients presenting 
with cytologically or histologically proven NSCLC 
or SCLC. Both curative and palliative stage were 
included, with stage being based on the intent of 
the anticancer treatment 
• Patients (n=63): CAU+MBSR (n=31); CAU (n=32) 
• Caregivers (n=44): CAU+MBRS (n=21); CAU 
(n=23) 
• NSCLC: intervention (n=28; 90%); control (n=26; 
81%) 
• SCLC: intervention (n=2; 7%); control  
(n=5; 16%) 
• Mesothelioma: intervention (n=1; 3%); control 
(n=1; 3%)
Care as usual plus 
mindfulness-based 
stress reduction (group-
based training in which 
participants practice 
mindfulness and receive 
teaching on stress)
Care as usual Primary 
• Psychological distress—Hospital Anxiety and Depression 
Scale (HADS) 
Secondary 
• QOL—EORTC QLQ-C30 
• Caregiver burden—Self-Perceived Pressure from 
Informal Care 
• Patient-caregiver relationship satisfaction (Investment 
Model Scale-Satisfaction subscale) 
• Mindfulness skills—Five Facet Mindfulness Questionnaire 
• Self-compassion—Self-Compassion Scale 
• Post-traumatic stress symptoms—Impact of Event Scale
• Significantly less psychological 
distress (P=0.008, d=0.69) in the 
intervention than the control 
• Baseline distress moderated outcome: 
those with more distress benefitted 
most from MBSR 
• Patients showed more improvements 
in quality of life, mindfulness skills, self-
compassion, and rumination in the 
intervention than the control. In partners, 
no differences were found between 
groups
Findings suggest that 
psychological distress in 
lung cancer patients can 
be effectively treated with 
MBSR; no effect was found 
in partners (possibly because 
they were more focused on 
patients’ well-being rather 
than their own)
Mosher et al. 2016 (36); 
USA; pilot randomized 
trial; Single site
To examine the preliminary 
efficacy of telephone-based 
symptom management (TSM) 
for symptomatic lung cancer 
patients and their family 
caregivers
• Diagnosis of SCLC or NSCLC; people receiving 
hospice care at the time of enrolment were excluded 
• Total: patients (n=106); caregivers (n=106) 
TSM: patients (n=51); caregivers (n=51) 
• Education/support: patients (n=55); caregivers 
(n=55) 
• NSCLC: TSM (n=44; 86.27%); Education/support 
(n=49; 89.09%) 
• SCLC: TSM (n=7; 13.73%); Education/support 
(n=6; 10.91%)
4 sessions of telephone 
symptom management 
(TSM) consisting of 
cognitive-behavioral and 
emotion-focused therapy
4 sessions of education/
support
Primary 
• Patient and caregiver depressive and anxiety—Patient 
Health Questionnaire; Generalized Anxiety Disorder scale 
(GAD-7) 
• Patient physical symptoms—Brief Pain Inventory 
Short Form; Fatigue Symptom Inventory; Memorial 
Symptom Assessment Scale (frequency and severity of 
breathlessness and distress related to breathlessness) 
Secondary 
• Patients’ perceived ability to manage pain, other 
symptoms, and function & Caregiver confidence in their 
ability to manage symptoms—16-item standard self-
efficacy scale modified from the arthritis literature 
• Caregivers’ self-efficacy to manage own emotions—8 
items 
• Patient and caregiver perceived constraints on cancer-
related disclosure from the other dyad member—5 item 
social constrains scale 
• Caregiver burden—Caregiver Reaction Assessment
• No significant group differences for 
all patient outcomes and caregiver self-
efficacy for helping the patient manage 
symptoms and caregiving burden at 
weeks 2 and 6 post-intervention 
• Small effects in favor of TSM regarding 
caregiver self-efficacy for managing 
their own emotions and perceived social 
constraints from the patient 
• No significant change over time for 
study outcomes in either group
• Findings suggest that 
the brief telephone-based 
psychosocial intervention 
was not efficacious for 
symptomatic improvement in 
lung cancer patients and their 
family caregivers 
• Next steps include 
examining specific 
intervention components in 
relation to study outcomes, 
mechanisms of change, and 
differing intervention doses 
and modalities
Schofield et al. 2013 
(37); Australia; two-group 
randomized controlled 
trial; single site
To test the effectiveness of a 
multidisciplinary supportive 
care program based on 
systematic needs assessment 
in people with inoperable lung 
cancer
• Diagnosis of inoperable lung or pleural (including 
mesothelioma) cancer; scheduled to receive 
palliative external beam radiotherapy, palliative 
chemotherapy or radical radiotherapy and 
chemotherapy 
• Total (n=108): Intervention (n=55); Control (n=53) 
• SCLC: intervention (n=4; 7.3%); control (n=5; 
9.4%) 
• NSCLC: intervention (n=48; 87.3%); control (n=45; 
84.9%) 
• Mesothelioma: intervention (n=3; 5.5%); control 
(n=3; 5.7%)
2 consultations at 
treatment commencement 
and completion and the 
provision of a systematic 
needs assessment 
data to the patient’s 
multidisciplinary team 
(MDT)
Usual care (standard care 
as per hospital protocol –
multidisciplinary meetings 
with referrals to allied 
health and palliative care 
as required; no systematic 
assessment/management 
patient need or systematic 
communication of patient 
needs)
Primary 
• Unmet needs—Needs Assessment for Advanced Lung 
Cancer Patients 
• Psychological morbidity—HADS 
• Global distress—Distress Thermometer (DT) 
• Health related QOL—EORTC QLQ-C30 V2.0
• Trial closed prematurely 
• No significant difference for any of the 
primary measures (all P>0.10) 
• Change score analysis indicated a 
relative benefit from the intervention for 
unmet symptom needs at week 8 and 
12 post-assessment (effect size =0.55 
and 0.40, respectively)
Novel approach, but 
the hypothesis that the 
intervention would benefit 
perceived unmet needs, 
psychological morbidity, 
distress and health-related 
quality of life was not 
supported overall
Table S3 TIDieR table describing early palliative care interventions
Author, year Intervention Who provided How Where When/how much Tailoring Modification Fidelity
El-Jawahri  
et al. 2017 
(28)
Patients assigned to early palliative care met with board 
certified palliative care physician or advance practice 
nurse
Certified palliative care physician or 
advance practice nurse
Face to face, 
or over the 
phone
In clinic Within 4 weeks of patient enrolment, 
and at least monthly palliative care 
visits until death
Not available Not available (I) 229 and 183 caregivers completed the week 12 
and week 24 assessments with a missing data rate of 
16.7% and 33.5%, respectively. (II) Intervention: 110/137 
caregivers completed 12 week follow up assessment; 
89/110 completed 24 week follow-up assessment. (III) 
Control: 119/138 caregivers completed 12-week follow 
up assessment, 94/119 completed 24 week follow-up 
assessment
Groenvold  
et al. 2017 
(29)
‘Early specialist palliative care’ was defined as ‘usual 
specialist palliative care’ initiated at earlier time than 
otherwise. Patients in the intervention group were referred 
to a specialist palliative care team
Specialist palliative care teams 
depended on the different specialized 
palliative care centers in the study. 
Members included doctors, nurses, 
physiotherapist, psychologists, social 
workers, chaplains, secretary, and 
volunteers, or pharmacists
Face-to-face 
or over the 
phone
In clinic Frequency was tailored to patient 
need
Primary outcome was tailored to the 
patient by being the patient’s most 
pronounced symptom/problem (‘primary 
need’); number and frequency of contacts 
with the specialist palliative care team and 
the treatments and other interventions 
were determined by the patient’s needs
Not available (I) Intervention: 138/145 received allocated intervention; 
32 were lost to follow up (15 died, 9 did not answer 
questionnaire, 8 due to administrative failure). (II) Control: 
139/152 received the allocated intervention; 39 were lost to 
follow up (15 died, 20 did not answer questionnaire, 4 due 
to administrative failure)
Temel et al. 
2017 (27)
Patients assigned to early palliative care met with board 
certified Palliative care physician or advance practice 
nurse
Certified palliative care physician or 
Advance practice nurse
Face to face, 
or over the 
phone
In clinic Within 4 weeks of patient enrolment, 
and at least monthly palliative care 
visits until death
Not available Not available (I) Intervention: 148/175 patients completed 12 week 
assessment; 118/148 completed 24 week assessment. 
(II) Control: 153/175 patients completed 12 assessment; 
125/153 completed 24 week assessment
Bakitas et al. 
2015 (30)
ENABLE (Educate, Nurture, Advise, Before Life Ends) 
includes initial in-person, standardized outpatient 
palliative care consultation by a board-certified palliative 
care clinician and structured telephone coaching sessions 
by an APN using a manualized curriculum
Palliative care consultation was 
conducted by a board certified palliative 
care clinician; telephone coaching was 







In clinic Early group: within 30 to 60 days 
of being informed of an advanced 
cancer diagnosis, cancer recurrence, 
or profession, in the opinion of the 
oncologist, prognosis between 6 and 
24 months. Delated group: patients 
were referred to first palliative care 
visit 3 months later
Not available Not available (I) Allocated to early intervention: 92/104 patients 
received the allocation intervention (9 did not start the 
intervention; 3 died before start); 33 patients discontinued 
the intervention (reasons: not interested (n=14), passive 
withdrawal (n=6), overwhelmed (n=6), moved care (n=3), 
too ill (n=2), too well (n=1), no reason (n=1)). (II) Allocated 
to delayed intervention: 81/103 patients received the 
allocation intervention (8 did not start the intervention; 14 
died before start); 27 patients discontinued the intervention 
[reasons: not interested (n=11), passive withdrawal (n=4), 
overwhelmed (n=3), moved care (n=3), too ill (n=1), too well 
(n=5), no reason (n=0)]
Dionne-
Odom et al. 
2015 (31)
ENABLE includes initial in-person, standardized 
outpatient PC consultation and structured telephone 
coaching sessions designed for caregivers. Caregivers 
were encouraged to be present the in-person palliative 
care consultation
Consultations by a board-certified 
palliative care physician; coaching 








In clinic or 
over the 
phone
(I) Early group: within 30 to 60 days 
of being informed of an advanced 
cancer diagnosis, cancer recurrence, 
or profession, in the opinion of the 
oncologist, prognosis between 6 
and 24 months. (II) Delayed group: 
3 months later. (III) Three caregiver 
educational sessions, once a week, 
delivered by nurses
Not available Not available (I) Early group: 61/63 enrolled caregivers provided data for 
analysis. 27 patients died with an enrolled caregiver. (II) 
Delayed group: all enrolled caregivers provided data, 39 
patients died with an enrolled caregiver
McCorkle  
et al. 2015 
(26)
10-week standardized intervention which included 
monitoring patients’ status, providing symptom 
management, executing complex care procedures, 
teaching patients and family caregivers, clarifying the 
illness experience, coordinating care, responding to the 
family, enhancing QOL, and collaborating with other 
providers
Clinic advance practice nurses 
contacted patients, and trained  
physician assistants and medical social 
workers to be part of multidisciplinary 
team
Face-to-face, 
or over the 
phone
In clinic Clinic advance practice nurses 
initially contacted patients within 24 
hours, and weekly phone and in-
person contacts were scheduled (five 
clinic visits and five telephone calls 
in total)
Not available Not available (I) Fidelity was assessed and monitored by the study 
advance practice nurse coordinator through quantification 
of whether the scheduled patient contacts occurred 
according to the protocol’s timeframe and review of 
10% of the documentation by the team members to 
ensure compliance with study protocols. (II) Intervention: 
54/66 completed one-month follow-up assessment; 
36/54 completed three-month follow-up assessment. (III) 
Control: 68/80 patients completed one-month follow-up 
assessment; 54/66 patients completed three-month follow-
up assessment
Zimmerman  
et al. 2014 
(32)
Consultation and follow-up in the oncology palliative 
care clinic. Intervention consisted of: (I) comprehensive, 
multidisciplinary assessment of symptoms; (II) routine 
telephone contact from a palliative care nurse; (III) monthly 
outpatient palliative care follow-up; and (IV) a 24-h on-call 
service for telephone management of urgent issues
Early palliative care intervention: 
palliative care physician and nurse, 
home palliative care physician (either 
for back up support to family physicians 
doing house calls or direct care if the 
family physician does not provide house 
calls). Standard care: oncologist and 
oncology nurses
Face-to-face 
















Assessment was within 1 month of 
recruitment (60–90 min in duration); 
routine phone call from palliative care 
nurse 1 week after first consultation 
and thereafter as needed; monthly 
outpatient palliative care follow-up
Ancillary interventions provided depended 
on the status of the patient
Not available (I) Intervention: 201/228 patients completed at least one 
follow up assessment; 29 patients died, 41 patients 
withdrew; 131 patients completed the study. (II) Control: 
192/233 patients completed at least one follow-up 
assessment; 9 patients died and 28 patients withdrew from 
follow up; 155 patients completed study
Temel et al. 
2010 (13)
Patients assigned to early palliative care met with a 
member of the palliative care team within 3 weeks of 
enrolment and at least monthly thereafter until death
Board certified palliative care physicians 
and advance practice nurses
Face-to-face 
visits
In clinics Within 3 weeks after enrolment and 
at least monthly thereafter in the 
outpatient setting until death
Additional visits with the palliative care service 
were scheduled at the discretion of the 
patient, oncologist, or palliative care provider
Not available All the patients assigned to early palliative care, except for 
one patient who died within 2 weeks after enrolment, had 
at least one visit with the palliative care service by week 12
